Results 31 to 40 of about 332,330 (302)

Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice

Haematologica, 2015
Ocular chronic graft-versus-host disease is one of the most bothersome common complications following allogeneic hematopoietic stem cell transplantation.
Lauren M. Curtis, Manuel B. Datiles, Seth M. Steinberg, Sandra A. Mitchell, Rachel J. Bishop, Edward W. Cowen, Jacqueline Mays, John M. McCarty, Zoya Kuzmina, Filip Pirsl, Daniel H. Fowler, Ronald E. Gress, Steven Z. Pavletic   +12 more
doaj   +1 more source

acute exacerbation of graft-versus-host disease

, 2023
Photography at presentation. (A) Image of right eye (RE) showed prominent anterior chamber inflammation with posterior synechiae. Band keratopathy was due to ocular graft-versus-host disease and keratoconjunctivitis sicca.
Chen-Yu Lin (14613215)
core   +1 more source

Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups

Haematologica, 2016
Graft-versus-host disease-free relapse-free survival, which is defined as the absence of grade III–IV acute graft-versus-host disease, systemically treated chronic graft-versus-host disease, relapse, and death, is a novel, meaningful composite end point ...
Yoshihiro Inamoto, Fumihiko Kimura, Junya Kanda, Junichi Sugita, Kazuhiro Ikegame, Hideki Nakasone, Yasuhito Nannya, Naoyuki Uchida, Takahiro Fukuda, Kosuke Yoshioka, Yukiyasu Ozawa, Ichiro Kawano, Yoshiko Atsuta, Koji Kato, Tatsuo Ichinohe, Masami Inoue, Takanori Teshima   +16 more
doaj   +1 more source

Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide

Haematologica, 2017
Composite endpoints that not only encompass mortality and relapse, but other critical post-transplant events such as graft-versus-host disease, are being increasingly utilized to quantify survival without significant morbidity after allogeneic blood or ...
Shannon R. McCurdy, Yvette L. Kasamon, Christopher G. Kanakry, Javier Bolaños-Meade, Hua-Ling Tsai, Margaret M. Showel, Jennifer A. Kanakry, Heather J. Symons, Ivana Gojo, B. Douglas Smith, Maria P. Bettinotti, William H. Matsui, Amy E. Dezern, Carol Ann Huff, Ivan Borrello, Keith W. Pratz, Douglas E. Gladstone, Lode J. Swinnen, Robert A. Brodsky, Mark J. Levis, Richard F. Ambinder, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik   +24 more
doaj   +1 more source

Chronic graft-versus-host disease: clinical presentation of multiple lesions of lichenoid and atrophic pattern [PDF]

Anais Brasileiros de Dermatologia, 2013
Graft-versus-host disease is observed mainly in recipients of hematopoietic cell transplantation and is expressed by cutaneous or systemic signals and symptoms. Graft-versus-host disease is clinically classified as acute or chronic.
Luiza Vasconcelos, Erica Cristina Vieira, Eliana Maria Minicucci, Ana Gabriela Salvio, Mair Pedro de Souza, Mariangela Esther Alencar Marques, Silvio Alencar Marques   +6 more
doaj   +1 more source

Human Mesenchymal Stem Cell Therapy for Acute Graft Versus Host Disease [PDF]

, 2016
Acute graft versus host disease (GVHD) is the most critical complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The understanding of major histocompatibility complex (MHC) and the development of acute GVHD prophylaxis have ...
Miura, Yasuo, Yoshioka, Satoshi
core   +1 more source

PET assessment of acute gastrointestinal graft versus host disease

, 2023
Acute gastrointestinal graft versus host disease (GI-GVHD) is a common complication following allogeneic haematopoietic cell transplantation (HCT), and is characterised by severe morbidity, frequent treatment-refractoriness, and high mortality.
Glen A. Kennedy, Siok-Keen Tey, Henden, Andrea, Kennedy, Glen AA, Ashleigh P. Scott, Scott, Ashleigh PP, Andrea Henden, Tey, Siok-Keen   +7 more
core   +1 more source

Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab

Haematologica, 2009
Background A variety of immune pathways can lead to graft-versus-host disease. A better understanding of the type of immune response causing graft-versus-host disease in defined clinical hematopoietic stem cell transplant settings is required to inform ...
Katie Matthews, ZiYi Lim, Behdad Afzali, Laurence Pearce, Atiyeh Abdallah, Shahram Kordasti, Antonio Pagliuca, Giovanna Lombardi, J. Alejandro Madrigal, Ghulam J. Mufti, Linda D. Barber   +10 more
doaj   +1 more source

Lichenoid variant of chronic cutaneous graft versus host reaction post blood transfusion: A rare event post blood transfusion

Indian Journal of Dermatology, 2015
Chronic graft versus host disease (GVHD) is a less frequently seen disease that occurs post solid organ or bone marrow transplantation. Chronic GVHD occurring post blood transfusion is an even more uncommon disease.
Pushpa Kodipalya Ramakrishnaiah, Archana Lakshman, Sacchidanand Sarvajnamurthy Aradhya, Nataraja Holavanahally Veerabhadrappa   +3 more
doaj   +1 more source

Graft-versus-Host Disease: Review

, 2019
Graft-versus-host Disease (GVHD) is a major complication with high morbidity and mortality rates on patients undergoing hematopoietic stem cell transplantation.
Tulio Batista Abud (6543074), Antonio Di Zazzo (827192), Lauro Augusto de Oliveira (4958032), Luciene Barbosa de Sousa (4958035)   +3 more
core   +1 more source